A review identified several additional genes, including MAPT, SLC2A13, ApoE, NOS2A, GRIN2A, CYP1A2, and ADORA2A, that may interact with caffeine to modify PD risk, highlighting the genetic and environmental interplay in PD pathogenesis [121]. This evidence concerns the gene NOS2 and Parkinson disease.